Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma
Gespeichert in:
| Veröffentlicht in: | British journal of cancer 1992-02, Vol.65 (2), p.303-304 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 304 |
|---|---|
| container_issue | 2 |
| container_start_page | 303 |
| container_title | British journal of cancer |
| container_volume | 65 |
| creator | Mulder, N H de Vries, E G Sleijfer, D T Schraffordt Koops, H Willemse, P H |
| description | |
| doi_str_mv | 10.1038/bjc.1992.61 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1977744</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72803828</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-6f18cb295e801c3054338ef2d9556d6745c2ff783ccfc87982f820259431cf9a3</originalsourceid><addsrcrecordid>eNpVkc9rFDEYhoModa2ePIs5SYvOmh-TSXIRZFu1UBCknsM3maSbMpOsyYxg_3qz3dLqKSTvy5MveRB6TcmaEq4-9jd2TbVm644-QSsqOGuoYvIpWhFCZEM0I8_Ri1Ju6lYTJY_QEZVcd1ys0O0ZWMg93Ibo8MnZ1cXm9APeLhNEnJ1NUx8ixBmHOLvsXU4Rw7jbAmaAT36ku5NTDHHAovHjknJaMtgwYp8yHkIpbqqA2Q14gjFc37EmN0JME7xEzzyMxb26X4_Rzy_nV5tvzeX3rxebz5eNbQmZm85TZXumhVOEWk5Ey7lyng1aiG7oZCss814qbq23SmrFvGKECd1yar0Gfow-Hbi7pZ_cYF2cM4xml8ME-Y9JEMz_SQxbc51-G6qllG1bAe_uATn9WlyZzRSKdWN9hktLMZKpqoGpWnx_KNqcSsnOP1xCidmrMlWV2asyHa3tN__O9dg9uKn520NeP3DJ7iGvjD2iEv4C_gybTw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72803828</pqid></control><display><type>article</type><title>Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma</title><source>MEDLINE</source><source>Nature</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Mulder, N H ; de Vries, E G ; Sleijfer, D T ; Schraffordt Koops, H ; Willemse, P H</creator><creatorcontrib>Mulder, N H ; de Vries, E G ; Sleijfer, D T ; Schraffordt Koops, H ; Willemse, P H</creatorcontrib><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.1992.61</identifier><identifier>PMID: 1739635</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Brain Neoplasms - prevention & control ; Dacarbazine - administration & dosage ; Drug Administration Schedule ; Female ; Fluorouracil - administration & dosage ; Humans ; Interferon-alpha - administration & dosage ; Male ; Melanoma - drug therapy ; Middle Aged</subject><ispartof>British journal of cancer, 1992-02, Vol.65 (2), p.303-304</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-6f18cb295e801c3054338ef2d9556d6745c2ff783ccfc87982f820259431cf9a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977744/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977744/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,2725,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1739635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mulder, N H</creatorcontrib><creatorcontrib>de Vries, E G</creatorcontrib><creatorcontrib>Sleijfer, D T</creatorcontrib><creatorcontrib>Schraffordt Koops, H</creatorcontrib><creatorcontrib>Willemse, P H</creatorcontrib><title>Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Brain Neoplasms - prevention & control</subject><subject>Dacarbazine - administration & dosage</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Fluorouracil - administration & dosage</subject><subject>Humans</subject><subject>Interferon-alpha - administration & dosage</subject><subject>Male</subject><subject>Melanoma - drug therapy</subject><subject>Middle Aged</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc9rFDEYhoModa2ePIs5SYvOmh-TSXIRZFu1UBCknsM3maSbMpOsyYxg_3qz3dLqKSTvy5MveRB6TcmaEq4-9jd2TbVm644-QSsqOGuoYvIpWhFCZEM0I8_Ri1Ju6lYTJY_QEZVcd1ys0O0ZWMg93Ibo8MnZ1cXm9APeLhNEnJ1NUx8ixBmHOLvsXU4Rw7jbAmaAT36ku5NTDHHAovHjknJaMtgwYp8yHkIpbqqA2Q14gjFc37EmN0JME7xEzzyMxb26X4_Rzy_nV5tvzeX3rxebz5eNbQmZm85TZXumhVOEWk5Ey7lyng1aiG7oZCss814qbq23SmrFvGKECd1yar0Gfow-Hbi7pZ_cYF2cM4xml8ME-Y9JEMz_SQxbc51-G6qllG1bAe_uATn9WlyZzRSKdWN9hktLMZKpqoGpWnx_KNqcSsnOP1xCidmrMlWV2asyHa3tN__O9dg9uKn520NeP3DJ7iGvjD2iEv4C_gybTw</recordid><startdate>19920201</startdate><enddate>19920201</enddate><creator>Mulder, N H</creator><creator>de Vries, E G</creator><creator>Sleijfer, D T</creator><creator>Schraffordt Koops, H</creator><creator>Willemse, P H</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19920201</creationdate><title>Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma</title><author>Mulder, N H ; de Vries, E G ; Sleijfer, D T ; Schraffordt Koops, H ; Willemse, P H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-6f18cb295e801c3054338ef2d9556d6745c2ff783ccfc87982f820259431cf9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Brain Neoplasms - prevention & control</topic><topic>Dacarbazine - administration & dosage</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Fluorouracil - administration & dosage</topic><topic>Humans</topic><topic>Interferon-alpha - administration & dosage</topic><topic>Male</topic><topic>Melanoma - drug therapy</topic><topic>Middle Aged</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulder, N H</creatorcontrib><creatorcontrib>de Vries, E G</creatorcontrib><creatorcontrib>Sleijfer, D T</creatorcontrib><creatorcontrib>Schraffordt Koops, H</creatorcontrib><creatorcontrib>Willemse, P H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulder, N H</au><au>de Vries, E G</au><au>Sleijfer, D T</au><au>Schraffordt Koops, H</au><au>Willemse, P H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma</atitle><jtitle>British journal of cancer</jtitle><addtitle>Br J Cancer</addtitle><date>1992-02-01</date><risdate>1992</risdate><volume>65</volume><issue>2</issue><spage>303</spage><epage>304</epage><pages>303-304</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><cop>England</cop><pub>Nature Publishing Group</pub><pmid>1739635</pmid><doi>10.1038/bjc.1992.61</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0920 |
| ispartof | British journal of cancer, 1992-02, Vol.65 (2), p.303-304 |
| issn | 0007-0920 1532-1827 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1977744 |
| source | MEDLINE; Nature; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; SpringerLink Journals - AutoHoldings |
| subjects | Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Brain Neoplasms - prevention & control Dacarbazine - administration & dosage Drug Administration Schedule Female Fluorouracil - administration & dosage Humans Interferon-alpha - administration & dosage Male Melanoma - drug therapy Middle Aged |
| title | Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T18%3A57%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dacarbazine%20(DTIC),%20human%20recombinant%20interferon%20alpha%202a%20(Roferon)%20and%205-fluorouracil%20for%20disseminated%20malignant%20melanoma&rft.jtitle=British%20journal%20of%20cancer&rft.au=Mulder,%20N%20H&rft.date=1992-02-01&rft.volume=65&rft.issue=2&rft.spage=303&rft.epage=304&rft.pages=303-304&rft.issn=0007-0920&rft.eissn=1532-1827&rft_id=info:doi/10.1038/bjc.1992.61&rft_dat=%3Cproquest_pubme%3E72803828%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72803828&rft_id=info:pmid/1739635&rfr_iscdi=true |